Du Zheng-Gui, Wei Yong-Gang, Chen Ke-Fei, Li Bo
Department of Liver and Vascular Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):153-61. doi: 10.1016/s1499-3872(14)60025-4.
Surgical resection is an important curative treatment for hepatocellular carcinoma (HCC); however, some patients experience an unexpected recurrence even after hepatectomy. The present study aimed to investigate risk factors and predictive criteria for early and late recurrence of HCC after resection.
A retrospective analysis of 398 Chinese patients who received curative resection for HCC was conducted. Patients were divided into three groups: without recurrence, early recurrence, and late recurrence. Prognostic factors and predictive criteria for early and late recurrence were statistically analyzed.
The cumulative recurrence-free survival rates at 1, 2, 3, 4, and 5 years were 75.5%, 58.2%, 54.1%, 40.5%, and 28.7%, respectively. The distribution of the time to recurrence suggested that recurrence could be divided into early phase (before 2 years; n=164) and late phase (after 2 years; n=83). Cox's multivariate proportional hazard model analysis revealed that multiplicity of tumors (P=0.004) and venous infiltration (P=0.002) were independent risk factors associated with early recurrence. In contrast, indocyanine green retention rate at 15 minutes (P=0.007), serum albumin level (P=0.045), and HBeAg status (P=0.028) proved to be significant independent adverse prognostic factors for late recurrence. Patients with at least 1 of the 2 early recurrence risk factors (multiplicity of tumors ≥ 2 and venous infiltration) or with 2 or more late recurrence risk factors are often susceptible to recurrence (P=1.36e-4 and 1.0e-6, respectively).
Early and late recurrences correlate with different risk factors and predictive criteria. Early recurrence primarily results from intrahepatic metastases, while late recurrence may be multicentric in origin.
手术切除是肝细胞癌(HCC)的重要治愈性治疗方法;然而,一些患者即使在肝切除术后也会出现意外复发。本研究旨在探讨HCC切除术后早期和晚期复发的危险因素及预测标准。
对398例接受HCC根治性切除的中国患者进行回顾性分析。患者分为三组:无复发、早期复发和晚期复发。对早期和晚期复发的预后因素及预测标准进行统计学分析。
1、2、3、4和5年的累积无复发生存率分别为75.5%、58.2%、54.1%、40.5%和28.7%。复发时间分布表明,复发可分为早期(2年之前;n = 164)和晚期(2年之后;n = 83)。Cox多因素比例风险模型分析显示,肿瘤多灶性(P = 0.004)和静脉浸润(P = 0.002)是与早期复发相关的独立危险因素。相比之下,15分钟吲哚菁绿滞留率(P = 0.007)、血清白蛋白水平(P = 0.045)和HBeAg状态(P = 0.028)被证明是晚期复发的重要独立不良预后因素。具有至少1个早期复发危险因素(肿瘤多灶性≥2和静脉浸润)或2个或更多晚期复发危险因素的患者通常易复发(分别为P = 1.36e - 4和1.0e - 6)。
早期和晚期复发与不同的危险因素及预测标准相关。早期复发主要源于肝内转移,而晚期复发可能是多中心起源。